nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—CA2—osteoporosis	0.387	1	CbGaD
Brinzolamide—CA14—Zoledronate—osteoporosis	0.157	0.375	CbGbCtD
Brinzolamide—CA12—Zoledronate—osteoporosis	0.111	0.266	CbGbCtD
Brinzolamide—CA2—Zoledronate—osteoporosis	0.09	0.215	CbGbCtD
Brinzolamide—CYP3A4—Estropipate—osteoporosis	0.0109	0.026	CbGbCtD
Brinzolamide—CYP3A4—Calcitriol—osteoporosis	0.0109	0.026	CbGbCtD
Brinzolamide—CYP3A4—Ergocalciferol—osteoporosis	0.00869	0.0208	CbGbCtD
Brinzolamide—CYP3A4—Raloxifene—osteoporosis	0.00725	0.0174	CbGbCtD
Brinzolamide—CYP3A4—Ethinyl Estradiol—osteoporosis	0.00701	0.0168	CbGbCtD
Brinzolamide—CYP3A4—Cholecalciferol—osteoporosis	0.0056	0.0134	CbGbCtD
Brinzolamide—CYP3A4—Conjugated Estrogens—osteoporosis	0.00514	0.0123	CbGbCtD
Brinzolamide—CYP3A4—Estradiol—osteoporosis	0.00452	0.0108	CbGbCtD
Brinzolamide—Dorzolamide—CA2—osteoporosis	0.00334	1	CrCbGaD
Brinzolamide—Discomfort—Pamidronate—osteoporosis	0.000132	0.00104	CcSEcCtD
Brinzolamide—Agitation—Zoledronate—osteoporosis	0.000131	0.00104	CcSEcCtD
Brinzolamide—Skin disorder—Risedronate—osteoporosis	0.000131	0.00103	CcSEcCtD
Brinzolamide—Vision blurred—Conjugated Estrogens—osteoporosis	0.00013	0.00103	CcSEcCtD
Brinzolamide—Urticaria—Ibandronate—osteoporosis	0.00013	0.00102	CcSEcCtD
Brinzolamide—Malaise—Zoledronate—osteoporosis	0.000129	0.00102	CcSEcCtD
Brinzolamide—Vertigo—Zoledronate—osteoporosis	0.000129	0.00102	CcSEcCtD
Brinzolamide—Infection—Pamidronate—osteoporosis	0.000127	0.001	CcSEcCtD
Brinzolamide—Rhinitis—Estradiol—osteoporosis	0.000127	0.001	CcSEcCtD
Brinzolamide—Urticaria—Calcitriol—osteoporosis	0.000127	0.001	CcSEcCtD
Brinzolamide—Palpitations—Zoledronate—osteoporosis	0.000126	0.001	CcSEcCtD
Brinzolamide—Hypoaesthesia—Estradiol—osteoporosis	0.000126	0.000996	CcSEcCtD
Brinzolamide—Pharyngitis—Estradiol—osteoporosis	0.000126	0.000994	CcSEcCtD
Brinzolamide—Hypersensitivity—Estropipate—osteoporosis	0.000125	0.000991	CcSEcCtD
Brinzolamide—Nervous system disorder—Pamidronate—osteoporosis	0.000125	0.000991	CcSEcCtD
Brinzolamide—Urinary tract disorder—Estradiol—osteoporosis	0.000125	0.000989	CcSEcCtD
Brinzolamide—Vomiting—Etidronic acid—osteoporosis	0.000125	0.000989	CcSEcCtD
Brinzolamide—Cough—Zoledronate—osteoporosis	0.000125	0.000987	CcSEcCtD
Brinzolamide—Oedema peripheral—Estradiol—osteoporosis	0.000125	0.000986	CcSEcCtD
Brinzolamide—Tachycardia—Pamidronate—osteoporosis	0.000125	0.000986	CcSEcCtD
Brinzolamide—Connective tissue disorder—Estradiol—osteoporosis	0.000124	0.000984	CcSEcCtD
Brinzolamide—Urethral disorder—Estradiol—osteoporosis	0.000124	0.000982	CcSEcCtD
Brinzolamide—Rash—Etidronic acid—osteoporosis	0.000124	0.00098	CcSEcCtD
Brinzolamide—Dermatitis—Etidronic acid—osteoporosis	0.000124	0.00098	CcSEcCtD
Brinzolamide—Vertigo—Conjugated Estrogens—osteoporosis	0.000124	0.000979	CcSEcCtD
Brinzolamide—Hypertension—Zoledronate—osteoporosis	0.000124	0.000977	CcSEcCtD
Brinzolamide—Hypersensitivity—Alendronate—osteoporosis	0.000123	0.000976	CcSEcCtD
Brinzolamide—Headache—Etidronic acid—osteoporosis	0.000123	0.000974	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000123	0.000969	CcSEcCtD
Brinzolamide—Asthenia—Estropipate—osteoporosis	0.000122	0.000965	CcSEcCtD
Brinzolamide—Visual impairment—Estradiol—osteoporosis	0.000122	0.000965	CcSEcCtD
Brinzolamide—Myalgia—Zoledronate—osteoporosis	0.000122	0.000963	CcSEcCtD
Brinzolamide—Chest pain—Zoledronate—osteoporosis	0.000122	0.000963	CcSEcCtD
Brinzolamide—Arthralgia—Zoledronate—osteoporosis	0.000122	0.000963	CcSEcCtD
Brinzolamide—Palpitations—Conjugated Estrogens—osteoporosis	0.000122	0.000963	CcSEcCtD
Brinzolamide—Insomnia—Risedronate—osteoporosis	0.000122	0.000962	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000121	0.000956	CcSEcCtD
Brinzolamide—Paraesthesia—Risedronate—osteoporosis	0.000121	0.000955	CcSEcCtD
Brinzolamide—Pruritus—Estropipate—osteoporosis	0.00012	0.000952	CcSEcCtD
Brinzolamide—Discomfort—Zoledronate—osteoporosis	0.00012	0.000951	CcSEcCtD
Brinzolamide—Asthenia—Alendronate—osteoporosis	0.00012	0.000951	CcSEcCtD
Brinzolamide—Hypersensitivity—Ibandronate—osteoporosis	0.00012	0.00095	CcSEcCtD
Brinzolamide—Cough—Conjugated Estrogens—osteoporosis	0.00012	0.00095	CcSEcCtD
Brinzolamide—Dyspnoea—Risedronate—osteoporosis	0.00012	0.000948	CcSEcCtD
Brinzolamide—Hypotension—Pamidronate—osteoporosis	0.000119	0.000944	CcSEcCtD
Brinzolamide—Dry mouth—Zoledronate—osteoporosis	0.000119	0.000942	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000119	0.000941	CcSEcCtD
Brinzolamide—Fatigue—Ethinyl Estradiol—osteoporosis	0.000119	0.00094	CcSEcCtD
Brinzolamide—Pruritus—Alendronate—osteoporosis	0.000119	0.000937	CcSEcCtD
Brinzolamide—Dyspepsia—Risedronate—osteoporosis	0.000118	0.000936	CcSEcCtD
Brinzolamide—Eye disorder—Estradiol—osteoporosis	0.000118	0.000936	CcSEcCtD
Brinzolamide—Tinnitus—Estradiol—osteoporosis	0.000118	0.000934	CcSEcCtD
Brinzolamide—Hypersensitivity—Calcitriol—osteoporosis	0.000118	0.00093	CcSEcCtD
Brinzolamide—Cardiac disorder—Estradiol—osteoporosis	0.000118	0.000929	CcSEcCtD
Brinzolamide—Arthralgia—Conjugated Estrogens—osteoporosis	0.000117	0.000927	CcSEcCtD
Brinzolamide—Myalgia—Conjugated Estrogens—osteoporosis	0.000117	0.000927	CcSEcCtD
Brinzolamide—Chest pain—Conjugated Estrogens—osteoporosis	0.000117	0.000927	CcSEcCtD
Brinzolamide—Asthenia—Ibandronate—osteoporosis	0.000117	0.000926	CcSEcCtD
Brinzolamide—Nausea—Etidronic acid—osteoporosis	0.000117	0.000924	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000116	0.000921	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000116	0.000921	CcSEcCtD
Brinzolamide—Diarrhoea—Estropipate—osteoporosis	0.000116	0.00092	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Risedronate—osteoporosis	0.000116	0.000918	CcSEcCtD
Brinzolamide—Infection—Zoledronate—osteoporosis	0.000116	0.000917	CcSEcCtD
Brinzolamide—Fatigue—Risedronate—osteoporosis	0.000116	0.000917	CcSEcCtD
Brinzolamide—Insomnia—Pamidronate—osteoporosis	0.000116	0.000914	CcSEcCtD
Brinzolamide—Pruritus—Ibandronate—osteoporosis	0.000115	0.000913	CcSEcCtD
Brinzolamide—Pain—Risedronate—osteoporosis	0.000115	0.000909	CcSEcCtD
Brinzolamide—Angiopathy—Estradiol—osteoporosis	0.000115	0.000909	CcSEcCtD
Brinzolamide—Paraesthesia—Pamidronate—osteoporosis	0.000115	0.000908	CcSEcCtD
Brinzolamide—Diarrhoea—Alendronate—osteoporosis	0.000115	0.000907	CcSEcCtD
Brinzolamide—Asthenia—Calcitriol—osteoporosis	0.000115	0.000906	CcSEcCtD
Brinzolamide—Nervous system disorder—Zoledronate—osteoporosis	0.000115	0.000905	CcSEcCtD
Brinzolamide—Immune system disorder—Estradiol—osteoporosis	0.000114	0.000904	CcSEcCtD
Brinzolamide—Mediastinal disorder—Estradiol—osteoporosis	0.000114	0.000902	CcSEcCtD
Brinzolamide—Dyspnoea—Pamidronate—osteoporosis	0.000114	0.000901	CcSEcCtD
Brinzolamide—Tachycardia—Zoledronate—osteoporosis	0.000114	0.000901	CcSEcCtD
Brinzolamide—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000114	0.000899	CcSEcCtD
Brinzolamide—Somnolence—Pamidronate—osteoporosis	0.000114	0.000898	CcSEcCtD
Brinzolamide—Skin disorder—Zoledronate—osteoporosis	0.000113	0.000897	CcSEcCtD
Brinzolamide—Pruritus—Calcitriol—osteoporosis	0.000113	0.000893	CcSEcCtD
Brinzolamide—Diarrhoea—Raloxifene—osteoporosis	0.000113	0.000892	CcSEcCtD
Brinzolamide—Dyspepsia—Pamidronate—osteoporosis	0.000113	0.00089	CcSEcCtD
Brinzolamide—Dizziness—Estropipate—osteoporosis	0.000113	0.00089	CcSEcCtD
Brinzolamide—Alopecia—Estradiol—osteoporosis	0.000112	0.000885	CcSEcCtD
Brinzolamide—Infection—Conjugated Estrogens—osteoporosis	0.000112	0.000883	CcSEcCtD
Brinzolamide—Diarrhoea—Ibandronate—osteoporosis	0.000112	0.000883	CcSEcCtD
Brinzolamide—Decreased appetite—Pamidronate—osteoporosis	0.000111	0.000879	CcSEcCtD
Brinzolamide—Mental disorder—Estradiol—osteoporosis	0.000111	0.000877	CcSEcCtD
Brinzolamide—Dizziness—Alendronate—osteoporosis	0.000111	0.000876	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00011	0.000873	CcSEcCtD
Brinzolamide—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00011	0.000872	CcSEcCtD
Brinzolamide—Malnutrition—Estradiol—osteoporosis	0.00011	0.000872	CcSEcCtD
Brinzolamide—Erythema—Estradiol—osteoporosis	0.00011	0.000872	CcSEcCtD
Brinzolamide—Fatigue—Pamidronate—osteoporosis	0.00011	0.000871	CcSEcCtD
Brinzolamide—Tachycardia—Conjugated Estrogens—osteoporosis	0.00011	0.000868	CcSEcCtD
Brinzolamide—Urticaria—Ethinyl Estradiol—osteoporosis	0.00011	0.000866	CcSEcCtD
Brinzolamide—Pain—Pamidronate—osteoporosis	0.000109	0.000864	CcSEcCtD
Brinzolamide—Diarrhoea—Calcitriol—osteoporosis	0.000109	0.000864	CcSEcCtD
Brinzolamide—Skin disorder—Conjugated Estrogens—osteoporosis	0.000109	0.000863	CcSEcCtD
Brinzolamide—Hypotension—Zoledronate—osteoporosis	0.000109	0.000863	CcSEcCtD
Brinzolamide—Dizziness—Raloxifene—osteoporosis	0.000109	0.000862	CcSEcCtD
Brinzolamide—Flatulence—Estradiol—osteoporosis	0.000109	0.000859	CcSEcCtD
Brinzolamide—CA7—Metabolism—ATIC—osteoporosis	0.000109	0.00166	CbGpPWpGaD
Brinzolamide—Tension—Estradiol—osteoporosis	0.000108	0.000855	CcSEcCtD
Brinzolamide—Vomiting—Estropipate—osteoporosis	0.000108	0.000855	CcSEcCtD
Brinzolamide—Dysgeusia—Estradiol—osteoporosis	0.000108	0.000854	CcSEcCtD
Brinzolamide—Dizziness—Ibandronate—osteoporosis	0.000108	0.000853	CcSEcCtD
Brinzolamide—Rash—Estropipate—osteoporosis	0.000107	0.000848	CcSEcCtD
Brinzolamide—Dermatitis—Estropipate—osteoporosis	0.000107	0.000847	CcSEcCtD
Brinzolamide—Nervousness—Estradiol—osteoporosis	0.000107	0.000847	CcSEcCtD
Brinzolamide—Urticaria—Risedronate—osteoporosis	0.000107	0.000845	CcSEcCtD
Brinzolamide—Back pain—Estradiol—osteoporosis	0.000107	0.000843	CcSEcCtD
Brinzolamide—Headache—Estropipate—osteoporosis	0.000107	0.000843	CcSEcCtD
Brinzolamide—Vomiting—Alendronate—osteoporosis	0.000107	0.000842	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000106	0.000841	CcSEcCtD
Brinzolamide—Muscle spasms—Estradiol—osteoporosis	0.000106	0.000838	CcSEcCtD
Brinzolamide—Rash—Alendronate—osteoporosis	0.000106	0.000835	CcSEcCtD
Brinzolamide—Insomnia—Zoledronate—osteoporosis	0.000106	0.000835	CcSEcCtD
Brinzolamide—Dermatitis—Alendronate—osteoporosis	0.000106	0.000835	CcSEcCtD
Brinzolamide—Feeling abnormal—Pamidronate—osteoporosis	0.000105	0.000833	CcSEcCtD
Brinzolamide—Hypotension—Conjugated Estrogens—osteoporosis	0.000105	0.000831	CcSEcCtD
Brinzolamide—Headache—Alendronate—osteoporosis	0.000105	0.00083	CcSEcCtD
Brinzolamide—Paraesthesia—Zoledronate—osteoporosis	0.000105	0.000829	CcSEcCtD
Brinzolamide—Vomiting—Raloxifene—osteoporosis	0.000105	0.000829	CcSEcCtD
Brinzolamide—Dyspnoea—Zoledronate—osteoporosis	0.000104	0.000823	CcSEcCtD
Brinzolamide—Rash—Raloxifene—osteoporosis	0.000104	0.000822	CcSEcCtD
Brinzolamide—Dermatitis—Raloxifene—osteoporosis	0.000104	0.000821	CcSEcCtD
Brinzolamide—Somnolence—Zoledronate—osteoporosis	0.000104	0.000821	CcSEcCtD
Brinzolamide—Vomiting—Ibandronate—osteoporosis	0.000104	0.00082	CcSEcCtD
Brinzolamide—Tremor—Estradiol—osteoporosis	0.000103	0.000817	CcSEcCtD
Brinzolamide—Headache—Raloxifene—osteoporosis	0.000103	0.000816	CcSEcCtD
Brinzolamide—Rash—Ibandronate—osteoporosis	0.000103	0.000813	CcSEcCtD
Brinzolamide—Dermatitis—Ibandronate—osteoporosis	0.000103	0.000813	CcSEcCtD
Brinzolamide—Dyspepsia—Zoledronate—osteoporosis	0.000103	0.000813	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000102	0.00081	CcSEcCtD
Brinzolamide—Ill-defined disorder—Estradiol—osteoporosis	0.000102	0.000809	CcSEcCtD
Brinzolamide—Headache—Ibandronate—osteoporosis	0.000102	0.000808	CcSEcCtD
Brinzolamide—Insomnia—Conjugated Estrogens—osteoporosis	0.000102	0.000804	CcSEcCtD
Brinzolamide—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000102	0.000803	CcSEcCtD
Brinzolamide—Vomiting—Calcitriol—osteoporosis	0.000102	0.000803	CcSEcCtD
Brinzolamide—CA14—Metabolism—CA2—osteoporosis	0.000102	0.00155	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—OXCT1—osteoporosis	0.000102	0.00155	CbGpPWpGaD
Brinzolamide—Decreased appetite—Zoledronate—osteoporosis	0.000102	0.000803	CcSEcCtD
Brinzolamide—Agitation—Estradiol—osteoporosis	0.000101	0.000801	CcSEcCtD
Brinzolamide—Nausea—Estropipate—osteoporosis	0.000101	0.000799	CcSEcCtD
Brinzolamide—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000101	0.000798	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000101	0.000797	CcSEcCtD
Brinzolamide—Rash—Calcitriol—osteoporosis	0.000101	0.000796	CcSEcCtD
Brinzolamide—Fatigue—Zoledronate—osteoporosis	0.000101	0.000796	CcSEcCtD
Brinzolamide—CA12—Metabolism—PNP—osteoporosis	0.000101	0.00153	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—ATIC—osteoporosis	0.000101	0.00153	CbGpPWpGaD
Brinzolamide—Dermatitis—Calcitriol—osteoporosis	0.000101	0.000796	CcSEcCtD
Brinzolamide—Dyspnoea—Conjugated Estrogens—osteoporosis	0.0001	0.000792	CcSEcCtD
Brinzolamide—Headache—Calcitriol—osteoporosis	0.0001	0.000791	CcSEcCtD
Brinzolamide—Somnolence—Conjugated Estrogens—osteoporosis	0.0001	0.00079	CcSEcCtD
Brinzolamide—Pain—Zoledronate—osteoporosis	9.99e-05	0.000789	CcSEcCtD
Brinzolamide—Nausea—Alendronate—osteoporosis	9.96e-05	0.000787	CcSEcCtD
Brinzolamide—Malaise—Estradiol—osteoporosis	9.94e-05	0.000786	CcSEcCtD
Brinzolamide—Hypersensitivity—Risedronate—osteoporosis	9.91e-05	0.000783	CcSEcCtD
Brinzolamide—Vertigo—Estradiol—osteoporosis	9.91e-05	0.000783	CcSEcCtD
Brinzolamide—Dyspepsia—Conjugated Estrogens—osteoporosis	9.9e-05	0.000782	CcSEcCtD
Brinzolamide—Asthenia—Ethinyl Estradiol—osteoporosis	9.9e-05	0.000782	CcSEcCtD
Brinzolamide—CA6—Metabolism—OXCT1—osteoporosis	9.89e-05	0.00151	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—MGLL—osteoporosis	9.89e-05	0.00151	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—CA2—osteoporosis	9.89e-05	0.00151	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—CA2—osteoporosis	9.89e-05	0.00151	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—OXCT1—osteoporosis	9.89e-05	0.00151	CbGpPWpGaD
Brinzolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	9.82e-05	0.0015	CbGpPWpGaD
Brinzolamide—Nausea—Raloxifene—osteoporosis	9.79e-05	0.000774	CcSEcCtD
Brinzolamide—Decreased appetite—Conjugated Estrogens—osteoporosis	9.77e-05	0.000773	CcSEcCtD
Brinzolamide—Pruritus—Ethinyl Estradiol—osteoporosis	9.76e-05	0.000771	CcSEcCtD
Brinzolamide—Palpitations—Estradiol—osteoporosis	9.74e-05	0.00077	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	9.71e-05	0.000767	CcSEcCtD
Brinzolamide—Fatigue—Conjugated Estrogens—osteoporosis	9.69e-05	0.000766	CcSEcCtD
Brinzolamide—Nausea—Ibandronate—osteoporosis	9.69e-05	0.000766	CcSEcCtD
Brinzolamide—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	9.69e-05	0.00148	CbGpPWpGaD
Brinzolamide—Asthenia—Risedronate—osteoporosis	9.65e-05	0.000763	CcSEcCtD
Brinzolamide—CA6—Metabolism—MGLL—osteoporosis	9.64e-05	0.00147	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—MGLL—osteoporosis	9.64e-05	0.00147	CbGpPWpGaD
Brinzolamide—Feeling abnormal—Zoledronate—osteoporosis	9.62e-05	0.000761	CcSEcCtD
Brinzolamide—Cough—Estradiol—osteoporosis	9.62e-05	0.000761	CcSEcCtD
Brinzolamide—Pain—Conjugated Estrogens—osteoporosis	9.62e-05	0.00076	CcSEcCtD
Brinzolamide—Hypertension—Estradiol—osteoporosis	9.52e-05	0.000753	CcSEcCtD
Brinzolamide—Pruritus—Risedronate—osteoporosis	9.51e-05	0.000752	CcSEcCtD
Brinzolamide—Nausea—Calcitriol—osteoporosis	9.49e-05	0.00075	CcSEcCtD
Brinzolamide—Diarrhoea—Ethinyl Estradiol—osteoporosis	9.44e-05	0.000746	CcSEcCtD
Brinzolamide—Hypersensitivity—Pamidronate—osteoporosis	9.42e-05	0.000745	CcSEcCtD
Brinzolamide—Chest pain—Estradiol—osteoporosis	9.39e-05	0.000742	CcSEcCtD
Brinzolamide—Arthralgia—Estradiol—osteoporosis	9.39e-05	0.000742	CcSEcCtD
Brinzolamide—Myalgia—Estradiol—osteoporosis	9.39e-05	0.000742	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	9.32e-05	0.000737	CcSEcCtD
Brinzolamide—Urticaria—Zoledronate—osteoporosis	9.28e-05	0.000733	CcSEcCtD
Brinzolamide—Discomfort—Estradiol—osteoporosis	9.28e-05	0.000733	CcSEcCtD
Brinzolamide—CA4—Metabolism—FDPS—osteoporosis	9.26e-05	0.00141	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PKM—osteoporosis	9.26e-05	0.00141	CbGpPWpGaD
Brinzolamide—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	9.25e-05	0.00141	CbGpPWpGaD
Brinzolamide—CA1—C-MYB transcription factor network—MYC—osteoporosis	9.25e-05	0.00141	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—OXCT1—osteoporosis	9.24e-05	0.00141	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CA2—osteoporosis	9.24e-05	0.00141	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—OXCT1—osteoporosis	9.24e-05	0.00141	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CA2—osteoporosis	9.24e-05	0.00141	CbGpPWpGaD
Brinzolamide—Diarrhoea—Risedronate—osteoporosis	9.2e-05	0.000727	CcSEcCtD
Brinzolamide—Dry mouth—Estradiol—osteoporosis	9.18e-05	0.000726	CcSEcCtD
Brinzolamide—Asthenia—Pamidronate—osteoporosis	9.17e-05	0.000725	CcSEcCtD
Brinzolamide—Dizziness—Ethinyl Estradiol—osteoporosis	9.12e-05	0.000721	CcSEcCtD
Brinzolamide—Pruritus—Pamidronate—osteoporosis	9.04e-05	0.000715	CcSEcCtD
Brinzolamide—CA5B—Metabolism—MGLL—osteoporosis	9e-05	0.00137	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—MGLL—osteoporosis	9e-05	0.00137	CbGpPWpGaD
Brinzolamide—Infection—Estradiol—osteoporosis	8.94e-05	0.000707	CcSEcCtD
Brinzolamide—Urticaria—Conjugated Estrogens—osteoporosis	8.93e-05	0.000706	CcSEcCtD
Brinzolamide—Dizziness—Risedronate—osteoporosis	8.89e-05	0.000703	CcSEcCtD
Brinzolamide—CA2—Metabolism—FDPS—osteoporosis	8.87e-05	0.00135	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PKM—osteoporosis	8.87e-05	0.00135	CbGpPWpGaD
Brinzolamide—Nervous system disorder—Estradiol—osteoporosis	8.83e-05	0.000698	CcSEcCtD
Brinzolamide—Tachycardia—Estradiol—osteoporosis	8.78e-05	0.000694	CcSEcCtD
Brinzolamide—CA4—Metabolism—GPD2—osteoporosis	8.78e-05	0.00134	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PGLS—osteoporosis	8.78e-05	0.00134	CbGpPWpGaD
Brinzolamide—Vomiting—Ethinyl Estradiol—osteoporosis	8.77e-05	0.000693	CcSEcCtD
Brinzolamide—Diarrhoea—Pamidronate—osteoporosis	8.75e-05	0.000692	CcSEcCtD
Brinzolamide—Skin disorder—Estradiol—osteoporosis	8.74e-05	0.000691	CcSEcCtD
Brinzolamide—Rash—Ethinyl Estradiol—osteoporosis	8.7e-05	0.000688	CcSEcCtD
Brinzolamide—Dermatitis—Ethinyl Estradiol—osteoporosis	8.69e-05	0.000687	CcSEcCtD
Brinzolamide—Headache—Ethinyl Estradiol—osteoporosis	8.64e-05	0.000683	CcSEcCtD
Brinzolamide—Hypersensitivity—Zoledronate—osteoporosis	8.6e-05	0.00068	CcSEcCtD
Brinzolamide—CA12—Metabolism—OXCT1—osteoporosis	8.56e-05	0.0013	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CA2—osteoporosis	8.56e-05	0.0013	CbGpPWpGaD
Brinzolamide—Vomiting—Risedronate—osteoporosis	8.55e-05	0.000676	CcSEcCtD
Brinzolamide—CA1—Metabolism—FDPS—osteoporosis	8.51e-05	0.0013	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PKM—osteoporosis	8.51e-05	0.0013	CbGpPWpGaD
Brinzolamide—Rash—Risedronate—osteoporosis	8.48e-05	0.00067	CcSEcCtD
Brinzolamide—Dermatitis—Risedronate—osteoporosis	8.47e-05	0.00067	CcSEcCtD
Brinzolamide—Dizziness—Pamidronate—osteoporosis	8.45e-05	0.000668	CcSEcCtD
Brinzolamide—Headache—Risedronate—osteoporosis	8.42e-05	0.000666	CcSEcCtD
Brinzolamide—CA14—Metabolism—IDH2—osteoporosis	8.41e-05	0.00128	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PGLS—osteoporosis	8.41e-05	0.00128	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GPD2—osteoporosis	8.41e-05	0.00128	CbGpPWpGaD
Brinzolamide—Asthenia—Zoledronate—osteoporosis	8.38e-05	0.000662	CcSEcCtD
Brinzolamide—CA12—Metabolism—MGLL—osteoporosis	8.34e-05	0.00127	CbGpPWpGaD
Brinzolamide—Hypersensitivity—Conjugated Estrogens—osteoporosis	8.28e-05	0.000655	CcSEcCtD
Brinzolamide—Pruritus—Zoledronate—osteoporosis	8.26e-05	0.000653	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Estradiol—osteoporosis	8.2e-05	0.000648	CcSEcCtD
Brinzolamide—CA5A—Metabolism—IDH2—osteoporosis	8.2e-05	0.00125	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—IDH2—osteoporosis	8.2e-05	0.00125	CbGpPWpGaD
Brinzolamide—Nausea—Ethinyl Estradiol—osteoporosis	8.19e-05	0.000648	CcSEcCtD
Brinzolamide—Insomnia—Estradiol—osteoporosis	8.14e-05	0.000643	CcSEcCtD
Brinzolamide—Vomiting—Pamidronate—osteoporosis	8.13e-05	0.000643	CcSEcCtD
Brinzolamide—Paraesthesia—Estradiol—osteoporosis	8.08e-05	0.000639	CcSEcCtD
Brinzolamide—Asthenia—Conjugated Estrogens—osteoporosis	8.07e-05	0.000638	CcSEcCtD
Brinzolamide—CA1—Metabolism—GPD2—osteoporosis	8.07e-05	0.00123	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PGLS—osteoporosis	8.07e-05	0.00123	CbGpPWpGaD
Brinzolamide—Rash—Pamidronate—osteoporosis	8.06e-05	0.000637	CcSEcCtD
Brinzolamide—Dermatitis—Pamidronate—osteoporosis	8.05e-05	0.000637	CcSEcCtD
Brinzolamide—CA4—Metabolism—PNP—osteoporosis	8.03e-05	0.00122	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ATIC—osteoporosis	8.03e-05	0.00122	CbGpPWpGaD
Brinzolamide—Dyspnoea—Estradiol—osteoporosis	8.02e-05	0.000634	CcSEcCtD
Brinzolamide—Headache—Pamidronate—osteoporosis	8.01e-05	0.000633	CcSEcCtD
Brinzolamide—Somnolence—Estradiol—osteoporosis	8e-05	0.000632	CcSEcCtD
Brinzolamide—CA9—Cellular responses to stress—SOD2—osteoporosis	7.99e-05	0.00122	CbGpPWpGaD
Brinzolamide—Diarrhoea—Zoledronate—osteoporosis	7.99e-05	0.000632	CcSEcCtD
Brinzolamide—Nausea—Risedronate—osteoporosis	7.99e-05	0.000632	CcSEcCtD
Brinzolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	7.96e-05	0.00121	CbGpPWpGaD
Brinzolamide—Pruritus—Conjugated Estrogens—osteoporosis	7.96e-05	0.000629	CcSEcCtD
Brinzolamide—Dyspepsia—Estradiol—osteoporosis	7.92e-05	0.000626	CcSEcCtD
Brinzolamide—CA14—Metabolism—CYP27A1—osteoporosis	7.91e-05	0.00121	CbGpPWpGaD
Brinzolamide—Decreased appetite—Estradiol—osteoporosis	7.82e-05	0.000618	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Estradiol—osteoporosis	7.77e-05	0.000614	CcSEcCtD
Brinzolamide—Fatigue—Estradiol—osteoporosis	7.76e-05	0.000613	CcSEcCtD
Brinzolamide—Dizziness—Zoledronate—osteoporosis	7.72e-05	0.00061	CcSEcCtD
Brinzolamide—CA6—Metabolism—CYP27A1—osteoporosis	7.71e-05	0.00118	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—CYP27A1—osteoporosis	7.71e-05	0.00118	CbGpPWpGaD
Brinzolamide—Pain—Estradiol—osteoporosis	7.7e-05	0.000608	CcSEcCtD
Brinzolamide—CA14—Metabolism—ACP5—osteoporosis	7.69e-05	0.00117	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ATIC—osteoporosis	7.69e-05	0.00117	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PNP—osteoporosis	7.69e-05	0.00117	CbGpPWpGaD
Brinzolamide—Diarrhoea—Conjugated Estrogens—osteoporosis	7.69e-05	0.000608	CcSEcCtD
Brinzolamide—CA7—Metabolism—IDH2—osteoporosis	7.65e-05	0.00117	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—IDH2—osteoporosis	7.65e-05	0.00117	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—GPX1—osteoporosis	7.63e-05	0.00116	CbGpPWpGaD
Brinzolamide—Nausea—Pamidronate—osteoporosis	7.59e-05	0.0006	CcSEcCtD
Brinzolamide—CA5A—Metabolism—ACP5—osteoporosis	7.5e-05	0.00114	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—ACP5—osteoporosis	7.5e-05	0.00114	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PKM—osteoporosis	7.48e-05	0.00114	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—FDPS—osteoporosis	7.48e-05	0.00114	CbGpPWpGaD
Brinzolamide—Dizziness—Conjugated Estrogens—osteoporosis	7.44e-05	0.000588	CcSEcCtD
Brinzolamide—Vomiting—Zoledronate—osteoporosis	7.42e-05	0.000587	CcSEcCtD
Brinzolamide—Feeling abnormal—Estradiol—osteoporosis	7.42e-05	0.000586	CcSEcCtD
Brinzolamide—CA1—Metabolism—PNP—osteoporosis	7.38e-05	0.00112	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ATIC—osteoporosis	7.38e-05	0.00112	CbGpPWpGaD
Brinzolamide—Rash—Zoledronate—osteoporosis	7.36e-05	0.000582	CcSEcCtD
Brinzolamide—Dermatitis—Zoledronate—osteoporosis	7.36e-05	0.000582	CcSEcCtD
Brinzolamide—Headache—Zoledronate—osteoporosis	7.32e-05	0.000578	CcSEcCtD
Brinzolamide—CA7—Metabolism—CYP27A1—osteoporosis	7.2e-05	0.0011	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CYP27A1—osteoporosis	7.2e-05	0.0011	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—TPI1—osteoporosis	7.15e-05	0.00109	CbGpPWpGaD
Brinzolamide—Vomiting—Conjugated Estrogens—osteoporosis	7.15e-05	0.000565	CcSEcCtD
Brinzolamide—Urticaria—Estradiol—osteoporosis	7.15e-05	0.000565	CcSEcCtD
Brinzolamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	7.1e-05	0.00108	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GPD2—osteoporosis	7.09e-05	0.00108	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PGLS—osteoporosis	7.09e-05	0.00108	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—IDH2—osteoporosis	7.09e-05	0.00108	CbGpPWpGaD
Brinzolamide—Rash—Conjugated Estrogens—osteoporosis	7.09e-05	0.00056	CcSEcCtD
Brinzolamide—Dermatitis—Conjugated Estrogens—osteoporosis	7.08e-05	0.00056	CcSEcCtD
Brinzolamide—Headache—Conjugated Estrogens—osteoporosis	7.04e-05	0.000557	CcSEcCtD
Brinzolamide—CA7—Metabolism—ACP5—osteoporosis	7e-05	0.00107	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—ACP5—osteoporosis	7e-05	0.00107	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—TPI1—osteoporosis	6.97e-05	0.00106	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—TPI1—osteoporosis	6.97e-05	0.00106	CbGpPWpGaD
Brinzolamide—Nausea—Zoledronate—osteoporosis	6.94e-05	0.000548	CcSEcCtD
Brinzolamide—CA4—Metabolism—OXCT1—osteoporosis	6.82e-05	0.00104	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CA2—osteoporosis	6.82e-05	0.00104	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—P4HB—osteoporosis	6.73e-05	0.00103	CbGpPWpGaD
Brinzolamide—Nausea—Conjugated Estrogens—osteoporosis	6.68e-05	0.000528	CcSEcCtD
Brinzolamide—CA12—Metabolism—CYP27A1—osteoporosis	6.67e-05	0.00102	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—MGLL—osteoporosis	6.65e-05	0.00101	CbGpPWpGaD
Brinzolamide—Hypersensitivity—Estradiol—osteoporosis	6.63e-05	0.000524	CcSEcCtD
Brinzolamide—CA14—Metabolism—GAPDH—osteoporosis	6.6e-05	0.00101	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—P4HB—osteoporosis	6.55e-05	0.000999	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—P4HB—osteoporosis	6.55e-05	0.000999	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—OXCT1—osteoporosis	6.54e-05	0.000997	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—TPI1—osteoporosis	6.51e-05	0.000992	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—TPI1—osteoporosis	6.51e-05	0.000992	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ATIC—osteoporosis	6.49e-05	0.000989	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PNP—osteoporosis	6.49e-05	0.000989	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—ACP5—osteoporosis	6.49e-05	0.000989	CbGpPWpGaD
Brinzolamide—Asthenia—Estradiol—osteoporosis	6.46e-05	0.00051	CcSEcCtD
Brinzolamide—CA5A—Metabolism—GAPDH—osteoporosis	6.43e-05	0.000981	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—GAPDH—osteoporosis	6.43e-05	0.000981	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—RAP1A—osteoporosis	6.43e-05	0.00098	CbGpPWpGaD
Brinzolamide—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	6.38e-05	0.000973	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—MGLL—osteoporosis	6.38e-05	0.000972	CbGpPWpGaD
Brinzolamide—Pruritus—Estradiol—osteoporosis	6.37e-05	0.000503	CcSEcCtD
Brinzolamide—CA1—Metabolism—CA2—osteoporosis	6.27e-05	0.000956	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—OXCT1—osteoporosis	6.27e-05	0.000956	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—RAP1A—osteoporosis	6.27e-05	0.000955	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—RAP1A—osteoporosis	6.27e-05	0.000955	CbGpPWpGaD
Brinzolamide—Diarrhoea—Estradiol—osteoporosis	6.16e-05	0.000487	CcSEcCtD
Brinzolamide—CA5B—Metabolism—P4HB—osteoporosis	6.12e-05	0.000933	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—P4HB—osteoporosis	6.12e-05	0.000933	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—MGLL—osteoporosis	6.11e-05	0.000932	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—TPI1—osteoporosis	6.03e-05	0.000919	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—GAPDH—osteoporosis	6.01e-05	0.000916	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—GAPDH—osteoporosis	6.01e-05	0.000916	CbGpPWpGaD
Brinzolamide—Dizziness—Estradiol—osteoporosis	5.95e-05	0.00047	CcSEcCtD
Brinzolamide—CA5B—Metabolism—RAP1A—osteoporosis	5.85e-05	0.000892	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—RAP1A—osteoporosis	5.85e-05	0.000892	CbGpPWpGaD
Brinzolamide—Vomiting—Estradiol—osteoporosis	5.72e-05	0.000452	CcSEcCtD
Brinzolamide—Rash—Estradiol—osteoporosis	5.67e-05	0.000449	CcSEcCtD
Brinzolamide—Dermatitis—Estradiol—osteoporosis	5.67e-05	0.000448	CcSEcCtD
Brinzolamide—CA12—Metabolism—P4HB—osteoporosis	5.67e-05	0.000864	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—IDH2—osteoporosis	5.65e-05	0.000862	CbGpPWpGaD
Brinzolamide—Headache—Estradiol—osteoporosis	5.64e-05	0.000446	CcSEcCtD
Brinzolamide—CA12—Metabolism—GAPDH—osteoporosis	5.56e-05	0.000848	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CA2—osteoporosis	5.51e-05	0.000841	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—OXCT1—osteoporosis	5.51e-05	0.000841	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—IDH2—osteoporosis	5.42e-05	0.000826	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—RAP1A—osteoporosis	5.42e-05	0.000826	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—MGLL—osteoporosis	5.37e-05	0.000819	CbGpPWpGaD
Brinzolamide—Nausea—Estradiol—osteoporosis	5.35e-05	0.000423	CcSEcCtD
Brinzolamide—CA4—Metabolism—CYP27A1—osteoporosis	5.32e-05	0.00081	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—ENO1—osteoporosis	5.2e-05	0.000792	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—IDH2—osteoporosis	5.2e-05	0.000792	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ACP5—osteoporosis	5.17e-05	0.000788	CbGpPWpGaD
Brinzolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	5.16e-05	0.000786	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PSMA2—osteoporosis	5.12e-05	0.000781	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PSMA5—osteoporosis	5.12e-05	0.000781	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CYP27A1—osteoporosis	5.1e-05	0.000777	CbGpPWpGaD
Brinzolamide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	5.09e-05	0.000776	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—ENO1—osteoporosis	5.07e-05	0.000772	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—ENO1—osteoporosis	5.07e-05	0.000772	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PSMA5—osteoporosis	4.99e-05	0.000761	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PSMA2—osteoporosis	4.99e-05	0.000761	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PSMA2—osteoporosis	4.99e-05	0.000761	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PSMA5—osteoporosis	4.99e-05	0.000761	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ACP5—osteoporosis	4.96e-05	0.000756	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CYP27A1—osteoporosis	4.89e-05	0.000745	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—TPI1—osteoporosis	4.81e-05	0.000733	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ACP5—osteoporosis	4.75e-05	0.000725	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—ENO1—osteoporosis	4.73e-05	0.000721	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—ENO1—osteoporosis	4.73e-05	0.000721	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PSMA5—osteoporosis	4.66e-05	0.00071	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PSMA5—osteoporosis	4.66e-05	0.00071	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PSMA2—osteoporosis	4.66e-05	0.00071	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PSMA2—osteoporosis	4.66e-05	0.00071	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—TPI1—osteoporosis	4.61e-05	0.000703	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—IDH2—osteoporosis	4.57e-05	0.000697	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—P4HB—osteoporosis	4.52e-05	0.000689	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GAPDH—osteoporosis	4.44e-05	0.000676	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—TPI1—osteoporosis	4.42e-05	0.000674	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—ENO1—osteoporosis	4.38e-05	0.000668	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—P4HB—osteoporosis	4.33e-05	0.000661	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—RAP1A—osteoporosis	4.32e-05	0.000659	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PSMA5—osteoporosis	4.32e-05	0.000658	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PSMA2—osteoporosis	4.32e-05	0.000658	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP27A1—osteoporosis	4.3e-05	0.000655	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GAPDH—osteoporosis	4.25e-05	0.000648	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	4.23e-05	0.000645	CbGpPWpGaD
Brinzolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	4.18e-05	0.000638	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ACP5—osteoporosis	4.18e-05	0.000637	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	4.17e-05	0.000636	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—CYP19A1—osteoporosis	4.16e-05	0.000633	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—P4HB—osteoporosis	4.16e-05	0.000633	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—RAP1A—osteoporosis	4.14e-05	0.000632	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GAPDH—osteoporosis	4.08e-05	0.000622	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—CYP19A1—osteoporosis	4.05e-05	0.000617	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—CYP19A1—osteoporosis	4.05e-05	0.000617	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—RAP1A—osteoporosis	3.97e-05	0.000606	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—TPI1—osteoporosis	3.89e-05	0.000592	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CYP19A1—osteoporosis	3.78e-05	0.000576	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CYP19A1—osteoporosis	3.78e-05	0.000576	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—P4HB—osteoporosis	3.65e-05	0.000557	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GAPDH—osteoporosis	3.59e-05	0.000547	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CYP19A1—osteoporosis	3.5e-05	0.000534	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ENO1—osteoporosis	3.49e-05	0.000533	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—RAP1A—osteoporosis	3.49e-05	0.000532	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PSMA2—osteoporosis	3.44e-05	0.000525	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PSMA5—osteoporosis	3.44e-05	0.000525	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—ADCY5—osteoporosis	3.39e-05	0.000518	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—GPX1—osteoporosis	3.38e-05	0.000516	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ENO1—osteoporosis	3.35e-05	0.000511	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—ADCY5—osteoporosis	3.31e-05	0.000504	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—ADCY5—osteoporosis	3.31e-05	0.000504	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PSMA2—osteoporosis	3.3e-05	0.000503	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PSMA5—osteoporosis	3.3e-05	0.000503	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—GPX1—osteoporosis	3.3e-05	0.000503	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—GPX1—osteoporosis	3.3e-05	0.000503	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ENO1—osteoporosis	3.21e-05	0.000489	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PSMA2—osteoporosis	3.16e-05	0.000482	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PSMA5—osteoporosis	3.16e-05	0.000482	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—MTHFR—osteoporosis	3.12e-05	0.000476	CbGpPWpGaD
Brinzolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	3.1e-05	0.000473	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—ADCY5—osteoporosis	3.09e-05	0.000471	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—ADCY5—osteoporosis	3.09e-05	0.000471	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—GPX1—osteoporosis	3.08e-05	0.000469	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—GPX1—osteoporosis	3.08e-05	0.000469	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—MTHFR—osteoporosis	3.04e-05	0.000464	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—MTHFR—osteoporosis	3.04e-05	0.000464	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—ADCY5—osteoporosis	2.86e-05	0.000436	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—GPX1—osteoporosis	2.85e-05	0.000435	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—MTHFR—osteoporosis	2.84e-05	0.000433	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—MTHFR—osteoporosis	2.84e-05	0.000433	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ENO1—osteoporosis	2.82e-05	0.00043	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CYP19A1—osteoporosis	2.79e-05	0.000426	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PSMA2—osteoporosis	2.78e-05	0.000424	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PSMA5—osteoporosis	2.78e-05	0.000424	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CYP19A1—osteoporosis	2.68e-05	0.000408	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—MTHFR—osteoporosis	2.63e-05	0.000401	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CYP19A1—osteoporosis	2.57e-05	0.000391	CbGpPWpGaD
Brinzolamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.51e-05	0.000383	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—POMC—osteoporosis	2.5e-05	0.000381	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—IL6—osteoporosis	2.45e-05	0.000373	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—POMC—osteoporosis	2.43e-05	0.000371	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—POMC—osteoporosis	2.43e-05	0.000371	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ADCY5—osteoporosis	2.28e-05	0.000348	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GPX1—osteoporosis	2.27e-05	0.000347	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—POMC—osteoporosis	2.27e-05	0.000346	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—POMC—osteoporosis	2.27e-05	0.000346	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP19A1—osteoporosis	2.26e-05	0.000344	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	2.22e-05	0.000339	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	2.19e-05	0.000334	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ADCY5—osteoporosis	2.19e-05	0.000333	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GPX1—osteoporosis	2.18e-05	0.000332	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—POMC—osteoporosis	2.1e-05	0.000321	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—MTHFR—osteoporosis	2.1e-05	0.00032	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ADCY5—osteoporosis	2.1e-05	0.00032	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GPX1—osteoporosis	2.09e-05	0.000319	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—MTHFR—osteoporosis	2.01e-05	0.000307	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—MTHFR—osteoporosis	1.93e-05	0.000294	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ADCY5—osteoporosis	1.84e-05	0.000281	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GPX1—osteoporosis	1.84e-05	0.00028	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—MTHFR—osteoporosis	1.7e-05	0.000259	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—POMC—osteoporosis	1.68e-05	0.000256	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—POMC—osteoporosis	1.61e-05	0.000245	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—POMC—osteoporosis	1.54e-05	0.000235	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—POMC—osteoporosis	1.36e-05	0.000207	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—POMC—osteoporosis	1.34e-05	0.000204	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PKM—osteoporosis	1.26e-05	0.000192	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—FDPS—osteoporosis	1.26e-05	0.000192	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PGLS—osteoporosis	1.19e-05	0.000182	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GPD2—osteoporosis	1.19e-05	0.000182	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PNP—osteoporosis	1.09e-05	0.000166	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ATIC—osteoporosis	1.09e-05	0.000166	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—OXCT1—osteoporosis	9.28e-06	0.000142	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CA2—osteoporosis	9.28e-06	0.000142	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—MGLL—osteoporosis	9.05e-06	0.000138	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—IDH2—osteoporosis	7.69e-06	0.000117	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP27A1—osteoporosis	7.23e-06	0.00011	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ACP5—osteoporosis	7.04e-06	0.000107	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—TPI1—osteoporosis	6.54e-06	9.97e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—P4HB—osteoporosis	6.15e-06	9.37e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GAPDH—osteoporosis	6.04e-06	9.2e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—RAP1A—osteoporosis	5.88e-06	8.96e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ENO1—osteoporosis	4.75e-06	7.24e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PSMA2—osteoporosis	4.68e-06	7.14e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PSMA5—osteoporosis	4.68e-06	7.14e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP19A1—osteoporosis	3.8e-06	5.79e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ADCY5—osteoporosis	3.1e-06	4.73e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GPX1—osteoporosis	3.09e-06	4.72e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—MTHFR—osteoporosis	2.85e-06	4.35e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—POMC—osteoporosis	2.28e-06	3.48e-05	CbGpPWpGaD
